The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ACAD FINANCIAL STATEMENTS

ACADIA Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ACADACADIA Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.1 B $Gross Profit1 B $ · 91%Operating Income86.4 M $ · 8%Pre-tax Income121.4 M $ · 11%Net Income to Owners380.5 M $ · 33%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.1 B $+11.8%
Gross Profit1 B $+10.7%
Operating Income86.4 M $-63.5%
EBITDA116.1 M $-8.9%
Net Income to Owners380.5 M $+71.3%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.7 B
  • Equity1.3 B $75%
  • Current Liabilities361.4 M $21%
  • Long-term Liabilities74.9 M $4%

Key Figures

YoY change
Total Assets1.7 B $+42.2%
Total Liabilities436.3 M $+8.2%
Total Equity1.3 B $+58.9%
Cash & ST Investments956.5 M $+25.5%
Total Debt73.9 M $+31.2%
Net Debt-311.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M194.3 M $Operating-11.2 M $Investing51 M $Financing234.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow194.3 M $+3.4%
Capital Expenditures19.9 M $-89.9%
Free Cash Flow174.4 M $-6.8%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ACAD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.